Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07636213 · ClinicalTrials.gov registry record
BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence
A clinical trial, sponsored by University of Chicago.
- Not yet
- Registry status
- 270
- Enrollment target
NCT07636213: Clinical Trial study, sponsored by University of Chicago.
NCT07636213 is a clinical trial that has not yet begun recruiting, run by University of Chicago. The registered enrollment target is 270 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07636213 has not yet begun recruiting, sponsored by University of Chicago.
- NOT YET RECRUITING
- Registry status
- 270 participants
- Enrollment target
Study Summary
The purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specific to PBI is extremely limited, and could provide critical insight to outcome identification and clinical decision making. This data will be used to build the first comprehensive PBI Data Commons, biorepository, and imaging repository which will create the infrastructure necessary to close critical knowledge gaps, advance biomarker discovery specific to PBI, and provide the foundation for future research aimed at improving prognostication and treatment for patients with this devastating injury.
Primary Outcome
The primary objective of this prospective study is to build the first comprehensive PBI Data Commons, Biorepository, and Imaging Repository. Clinical data, biospecimens, and imaging from subjects with PBI will be prospectively collected and analyzed across multiple sites, which will then be used to build these resources.
Interventions
- OTHER Blood Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2035-12-31 |
What is known before NCT07636213 opens enrollment
NCT07636213 is an observational study that tracks outcomes without assigning an intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT07636213 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07636213 about?
NCT07636213 is a clinical study titled "BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence". The purpose of this research study is to prospectively collect biospecimens, imaging, and clinical data from patients with penetrating brain injuries across high-volume PBI sites in the US (including UChicago). Biospecimens will undergo biomarker analysis - biomarker data specific to PBI is extremel...
What is the current status of trial NCT07636213?
This trial is currently not yet recruiting. The enrollment target is 270 participants. The study started on 2026-07-01. Estimated completion is 2035-12-31.
What interventions are being tested in trial NCT07636213?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT07636213?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00801489 · 270 participants · Phase 2
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- NCT04372485 · 270 participants · NA
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
- NCT04528446 · 270 participants
The Impact of Glomerular Disorders on Bone Quality and Strength
- NCT05215327 · 270 participants · Phase 2
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI